ATRC
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSAtriCure, Inc. - Common Stock (ATRC) [ST]
www.atricure.com ↗▲ 2.82%
prev close
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Congressional Trades
1
All tracked trades
Members Trading
1
Unique members
Net Activity
+1
1 buys · 0 sells
Members Who Traded This Stock
1 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2024-07-19 | ATRCAtriCure, Inc. - Common Stock | Buy | $1,001 - $15,000 | 611d ago | — |
2024-07-19
Josh Gottheimer
ATRC
Amount
$1,001 - $15,000
Filed
611d ago
Recent News
Powered by Polygon.io
Is AtriCure Stock a Buy or Sell After a Director Dumped 10,000 Shares?
Questex’s Fierce Healthcare Announces 2025 Fierce DEI Award Finalists
AtriCure gains China's nod for heart surgery device - Investing.com
Cracking The Code: Understanding Analyst Reviews For AtriCure
Compared to Estimates, AtriCure (ATRC) Q1 Earnings: A Look at Key Metrics
Trade Timeline
Congressional activity, newest first
Josh Gottheimer
2024-07-19 · Purchase
$1,001 - $15,000